COVID-19 vaccine characteristics
Vaccine | WHO EUL holder | Doses/vial | Shelf-life | Storage |
COMIRNATY COVD-19 mRNA vaccine (nucleoside modified) | BioNTech Manufacturing GmbH | 6 | 9 months after date of manufacture for undiluted vaccine at storage temperature −90°C to −60°C |
|
VAXZEVRIA COVID-19 vaccine (ChAdOx1-S (recombinant)) | AstraZeneca AB/SK Bioscience Co. Ltd AstraZeneca AB | 10 | 6 months for unopened vials stored at 2–8°C |
|
COVISHIELD COVID-19 vaccine (ChAdOx1-S (recombinant)) | Serum Institute of India Pvt. Ltd | 10 | Unopened vials can be stored at 2–8°C for 6 months or up to 25°C for 2 hours Opened vials can be stored at 2–25°C for use within 6 hours |
|
COVID-19 vaccine (Ad26.COV2-S (recombinant)) | Janssen–Cilag International NV | 5 | Unopened vials −25°C to 15°C for 2 years Unopened vials 2–8°C for 4.5 months of printed expiration date Up to 25°C for 2 hours |
|
SPIKEVAX COVID-19 mRNA vaccine (nucleoside modified) | Moderna Biotech ModernaTX, Inc | 10, 15 | 9 months at storage temperature: 20°C±5°C |
|
Inactivated COVID-19 Vaccine (Vero Cell) | Beijing Institute of Biological Products Co., Ltd. (BIBP) | 1, 2 or 5 | 24 months |
|
CoronaVac COVID-19 vaccine (Vero Cell), inactivated | Sinovac Life Sciences Co., Ltd | 1, 2 and PFS | 12 months |
|
COVAXIN COVID-19 vaccine (whole virion inactivated corona virus vaccine) | Bharat Biotech International Ltd | 1, 5, 10, 20 | 9 months |
|
COVOVAX COVID-19 vaccine (SARS-CoV-2 rS protein nanoparticle (recombinant)) | Serum Institute of India Pvt. Ltd | 1, 10 | 9 months |
|
NUVAXOVID COVID-19 vaccine (SARS-CoV-2 rS (recombinant, adjuvanted)) | Novavax CZ a.s | 10 | 9 months |
|
EUL, Emergency use listing procedure; PFS, Prefilled syringe vaccine doses; ULT, Ultra low temperature .